Healthdirect Free Australian health advice you can count on.

Medical problem? Call 1800 022 222. If you need urgent medical help, call triple zero immediately

healthdirect Australia is a free service where you can talk to a nurse or doctor who can help you know what to do.

beginning of content

Imojev TM

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional.

Active ingredients: inert substance, japanese encephalitis live vaccine

Pack: Imojev (1 x vaccine vial, 1 x inert diluent vial), 1 pack

Brand name

(ARTG)

: IMOJEV japanese encephalitis vaccine (live, attenuated) powder for injection vial plus diluent vial

Download the Consumer Medicine Information Leaflet

Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website

What this medicine is used for

(ARTG)

IMOJEV is indicated for prophylaxis of Japanese encephalitis caused by the Japanese encephalitis virus, in individuals from 9 months of age and over.

How to use this medicine

(ARTG)

This medicine is a pack that contains more than one component.

Component :

  • Diluent, not applicable
  • Subcutaneous
  • Clear solution

Component :

  • Injection, powder for
  • Subcutaneous
  • A white to creamy white homogeneous cake which might be retracted.

Storage conditions

(ARTG)

  • Store at 2 to 8 degrees Celsius
  • Protect from Light
  • Do not Freeze
  • Shelf lifetime is 48 Months.

Do I need a prescription ?

(ARTG)

These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.

  • 1 powder vial and 1 diluent vial, 1 syringe and 2 needles pack

Pregnant or planning a pregnancy ?

(AHT)

For the active ingredient japanese encephalitis live vaccine

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

Back to top back to top

Need more information?

These trusted information partners have more on this topic.

Top results

Japanese encephalitis | NCIRS

Japanese encephalitis NCIRS fact sheets, FAQs and other resources Australian Immunisation Handbook COVID-19 vaccines Immunisation coverage data and reports Education and training History of immunisation Immunisation schedules National and international resources NCIRS fact sheets, FAQs and other resources COVID-19 DTPa-HB-IPV-Hib vaccine (Vaxelis® and Infanrix hexa®) Haemophilus influenzae type b (Hib) Hepatitis B Human papillomavirus Influenza Japanese encephalitis Measles Measles vaccination catch-up guide Meningococcal Mpox (formerly known as monkeypox) Mumps Pertussis Pneumococcal Poliomyelitis Respiratory syncytial virus (RSV) Rotavirus Rubella Varicella-zoster (chickenpox) Zoster (shingles) Injection site reactions Vaccine components Vaccines for Australian adults Vaccinations during pregnancy NCIRS webinar series Patient communication resources Specialist immunisation services SKAI - supporting health professionals NCIRS newsletters Vaccine safety NCIRS fact sheets, FAQs and other resources Australian Immunisation Handbook COVID-19 vaccines Immunisation coverage data and reports Education and training History of immunisation Immunisation schedules National and international resources NCIRS fact sheets, FAQs and other resources COVID-19 DTPa-HB-IPV-Hib vaccine (Vaxelis® and Infanrix hexa®) Haemophilus influenzae type b (Hib) Hepatitis B Human papillomavirus Influenza Japanese encephalitis Measles Measles vaccination catch-up guide Meningococcal Mpox (formerly known as monkeypox) Mumps Pertussis Pneumococcal Poliomyelitis Respiratory syncytial virus (RSV) Rotavirus Rubella Varicella-zoster (chickenpox) Zoster (shingles) Injection site reactions Vaccine components Vaccines for Australian adults Vaccinations during pregnancy NCIRS webinar series Patient communication resources Specialist immunisation services SKAI - supporting health professionals NCIRS newsletters Vaccine safety The Japanese encephalitis (JE) situation in Australia has been declared a Communicable Disease Incident of National Significance as of March 2022

Read more on National Centre for Immunisation Research and Surveillance (NCIRS) website

Healthdirect 24hr 7 days a week hotline

24 hour health advice you can count on

1800 022 222

Government Accredited with over 140 information partners

We are a government-funded service, providing quality, approved health information and advice

Australian Government, health department logo ACT Government logo New South Wales government, health department logo Northen Territory Government logo Queensland Government logo Government of South Australia, health department logo Tasmanian government logo Victorian government logo Government of Western Australia, health department logo

Healthdirect Australia acknowledges the Traditional Owners of Country throughout Australia and their continuing connection to land, sea and community. We pay our respects to the Traditional Owners and to Elders both past and present.

© 2024 Healthdirect Australia Limited